Percutaneous Nonviral Delivery of Hepatocyte Growth Factor in an Osteotomy Gap Promotes Bone Repair in Rabbits: a Preliminary Study

Overview

Journal Clin Orthop Relat Res

Publisher Wolters Kluwer

Specialty Orthopedics

Date 2008 Sep 25

PMID 18813894

Citations 5

Authors

Hidenori Matsubara

Hiroyuki Tsuchiya

Koji Watanabe

Akihiko Takeuchi

Katsuro Tomita

Affiliations

Soon will be listed here.

Abstract

Hepatocyte growth factor (HGF) was initially identified in cultured hepatocytes and subsequently reported to induce angiogenic, morphogenic, and antiapoptotic activity in various tissues. These properties suggest a potential influence of HGF on bone healing. We asked if gene transfer of human HGF (hHGF) into an osteotomy gap with a hemagglutinating virus of Japan-envelope (HVJ-E) vector promotes bone healing in rabbits. HVJ-E that contained either hHGF or control plasmid was percutaneously injected into the osteotomy gap of rabbit tibias on Day 14. The osteotomy gap was evaluated by radiography, pQCT, mechanical tests, and histology at Week 8. The expression of hHGF was evaluated by reverse transcriptase-polymerase chain reaction and immunohistochemistry at Week 3. Radiography, pQCT, and histology suggested the hHGF group had faster fracture healing. Mechanical tests demonstrated the hHGF group had greater mechanical strength. The injected tissues at 3 weeks expressed hHGF mRNA by reverse transcriptase-polymerase chain reaction. hHGF-positive immunohistochemical staining was observed in various cells at the osteotomy gap at Week 3. The data suggest delivery of hHGF plasmid into the osteotomy gap promotes fracture repair, and HGF could become a novel agent for fracture treatment.

Citing Articles

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis.

Deminger A, Klingberg E, Nurkkala M, Geijer M, Carlsten H, Jacobsson L Rheumatology (Oxford). 2020; 60(4):1804-1813.

PMID: 33106846 PMC: 8023989. DOI: 10.1093/rheumatology/keaa460.

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.

Torres L, Klingberg E, Nurkkala M, Carlsten H, Forsblad-dElia H Osteoporos Int. 2018; 30(2):441-449.

PMID: 30306221 PMC: 6449322. DOI: 10.1007/s00198-018-4721-4.

Preclinical therapies to prevent or treat fracture non-union: A systematic review.

Bennett P, Stewart S, Dretzke J, Bem D, Penn-Barwell J PLoS One. 2018; 13(8):e0201077.

PMID: 30067783 PMC: 6070249. DOI: 10.1371/journal.pone.0201077.

Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair.

Frisch R, Curtis K, Aenlle K, Howard G Expert Opin Ther Targets. 2016; 20(9):1087-98.

PMID: 26941128 PMC: 5031543. DOI: 10.1517/14728222.2016.1162293.

Effect of semisynthetic extracellular matrix-like hydrogel containing hepatocyte growth factor on repair of femoral neck defect in rabbits.

Liu P, Guo L, Huang L, Zhao D, Zhen R, Hu X Int J Clin Exp Med. 2015; 8(5):7374-80.

PMID: 26221278 PMC: 4509223.

References

Park S, OConnor K, Sung R, McKellop H, Sarmiento A . Comparison of healing process in open osteotomy model and closed fracture model. J Orthop Trauma. 1999; 13(2):114-20. DOI: 10.1097/00005131-199902000-00008. View

Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J . Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004; 44(2):203-9. DOI: 10.1161/01.HYP.0000136394.08900.ed. View

Shi E, Jiang X, Kazui T, Washiyama N, Yamashita K, Terada H . Nonviral gene transfer of hepatocyte growth factor attenuates neurologic injury after spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg. 2006; 132(4):941-7. DOI: 10.1016/j.jtcvs.2006.06.018. View

Matsushita T, Kurokawa T . Comparison of cyclic compression, cyclic distraction and rigid fixation. Bone healing in rabbits. Acta Orthop Scand. 1998; 69(1):95-8. DOI: 10.3109/17453679809002365. View

Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen J, Robbins P . Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat Res. 1999; (355 Suppl):S148-53. DOI: 10.1097/00003086-199810001-00016. View

Kawaguchi H, Nakamura K, Tabata Y, Ikada Y, Aoyama I, Anzai J . Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab. 2001; 86(2):875-80. DOI: 10.1210/jcem.86.2.7199. View

Shimamura M, Morishita R, Endoh M, Oshima K, Aoki M, Waguri S . HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun. 2002; 300(2):464-71. DOI: 10.1016/s0006-291x(02)02807-3. View

Alkhiary Y, Gerstenfeld L, Krall E, Westmore M, Sato M, Mitlak B . Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am. 2005; 87(4):731-41. DOI: 10.2106/JBJS.D.02115. View

Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N . Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 2006; 13(16):1206-13. DOI: 10.1038/sj.gt.3302740. View

10.

Radomsky M, Aufdemorte T, Swain L, Fox W, Spiro R, Poser J . Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res. 1999; 17(4):607-14. DOI: 10.1002/jor.1100170422. View

11.

Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, Uenoyama M . Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res. 2005; 52(4):299-310. DOI: 10.1016/j.neures.2005.04.004. View

12.

Musgrave D, Bosch P, Ghivizzani S, Robbins P, Evans C, Huard J . Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone. 1999; 24(6):541-7. DOI: 10.1016/s8756-3282(99)00086-1. View

13.

Lane J . Bone morphogenic protein science and studies. J Orthop Trauma. 2006; 19(10 Suppl):S17-22. DOI: 10.1097/00005131-200511101-00006. View

14.

Sekalska B, Ciechanowicz A, Dolegowska B, Naruszewicz M . Optimized RT-PCR method for assaying expression of monocyte chemotactic protein type 1 (MCP-1) in rabbit aorta. Biochem Genet. 2006; 44(3-4):133-43. DOI: 10.1007/s10528-006-9015-4. View

15.

Yoshimura S, Morishita R, Hayashi K, Kokuzawa J, Aoki M, Matsumoto K . Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension. 2002; 39(5):1028-34. DOI: 10.1161/01.hyp.0000017553.67732.e1. View

16.

Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K . Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001; 8(3):181-9. DOI: 10.1038/sj.gt.3301379. View

17.

Hirano S, Bless D, Rousseau B, Welham N, Montequin D, Chan R . Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope. 2004; 114(3):548-56. DOI: 10.1097/00005537-200403000-00030. View

18.

Hossain M, Irwin R, Baumann M, McCabe L . Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials. 2004; 26(15):2595-602. DOI: 10.1016/j.biomaterials.2004.07.051. View

19.

Eckardt H, Ding M, Lind M, Hansen E, Christensen K, Hvid I . Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br. 2005; 87(10):1434-8. DOI: 10.1302/0301-620X.87B10.16226. View

20.

Rundle C, Miyakoshi N, Kasukawa Y, Chen S, Sheng M, Wergedal J . In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. Bone. 2003; 32(6):591-601. DOI: 10.1016/s8756-3282(03)00096-6. View